Literature DB >> 21128718

Detection of macrophages via paramagnetic vesicles incorporating oxidatively tailored cholesterol ester: an approach for atherosclerosis imaging.

Andrei Maiseyeu1, Georgeta Mihai, Sashwati Roy, Nisharahmed Kherada, Orlando P Simonetti, Chandan K Sen, Qinghua Sun, Sampath Parthasarathy, Sanjay Rajagopalan.   

Abstract

AIM: Macrophages play a key role in the initiation, progression and complications of atherosclerosis. In this article we describe the synthesis of biocompatible, paramagnetic, fluorescent phosphatidylserine vesicles containing cholesterol ester with a free carboxylic acid function and its use for targeted imaging of macrophages. METHODS &
RESULTS: We synthesized anionic vesicles containing a combination of phosphatidylserine and a novel synthetic oxidized cholesterol ester derivative (cholesterol-9-carboxynonanoate [9-CCN]). In vitro studies to characterize particle size, MRI relaxation times and stability were performed. Vesicles containing 9-CCN demonstrated enhanced ability to bind human low-density lipoprotein and to be internalized by macrophages. Experiments in cultured macrophages with 9-CCN vesicles, alone and in the presence of low-density lipoprotein, indicated uptake of vesicles through scavenger receptor and integrin-dependent pathways. In vivo MRI using 9-CCN vesicles containing gadolinium in a rabbit model of atherosclerosis revealed protracted enhancement of 9-CCN vesicles and colocalization with arterial macrophages not seen with control vesicles. Pharmacokinetic experiments demonstrated prolonged plasma residence time of 9-CCN vesicles, perhaps due to its capacity to bind to low-density lipoprotein.
CONCLUSION: Vesicles containing 9-CCN demonstrate prolonged plasma and plaque retention in experimental atherosclerosis. Such a strategy may represent a simple yet clinically relevant approach for macrophage imaging.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21128718      PMCID: PMC3098505          DOI: 10.2217/nnm.10.87

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  44 in total

1.  Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.

Authors:  Mai-Lan N Huynh; Valerie A Fadok; Peter M Henson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages.

Authors:  K Kobayashi; E Matsuura; Q Liu; J Furukawa ; K Kaihara; J Inagaki; T Atsumi; N Sakairi; T Yasuda; D R Voelker; T Koike
Journal:  J Lipid Res       Date:  2001-05       Impact factor: 5.922

3.  Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals.

Authors:  Oliver T Bruns; Harald Ittrich; Kersten Peldschus; Michael G Kaul; Ulrich I Tromsdorf; Joachim Lauterwasser; Marija S Nikolic; Birgit Mollwitz; Martin Merkel; Nadja C Bigall; Sameer Sapra; Rudolph Reimer; Heinz Hohenberg; Horst Weller; Alexander Eychmüller; Gerhard Adam; Ulrike Beisiegel; Joerg Heeren
Journal:  Nat Nanotechnol       Date:  2009-01-25       Impact factor: 39.213

4.  Synergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis.

Authors:  Ewelina Kluza; Daisy W J van der Schaft; Petra A I Hautvast; Willem J M Mulder; Kevin H Mayo; Arjan W Griffioen; Gustav J Strijkers; Klaas Nicolay
Journal:  Nano Lett       Date:  2010-01       Impact factor: 11.189

5.  2D-NMR reveals different populations of exposed lysine residues in the apoB-100 protein of electronegative and electropositive fractions of LDL particles.

Authors:  Francisco J Blanco; Sandra Villegas; Sònia Benítez; Cristina Bancells; Tammo Diercks; Jordi Ordóñez-Llanos; José L Sánchez-Quesada
Journal:  J Lipid Res       Date:  2010-01-28       Impact factor: 5.922

6.  Mineralocorticoid receptor antagonism in experimental atherosclerosis.

Authors:  Sanjay Rajagopalan; Damon Duquaine; Steven King; Bertram Pitt; Paresh Patel
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

7.  The clinical utility of liposomal doxorubicin in recurrent ovarian cancer.

Authors:  S M Campos; R T Penson; A R Mays; R S Berkowitz; A F Fuller; A Goodman; U A Matulonis; A Muzikansky; M V Seiden
Journal:  Gynecol Oncol       Date:  2001-05       Impact factor: 5.482

8.  Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages.

Authors:  Qingping Liu; Kazuko Kobayashi; Jun-ichi Furukawa; Junko Inagaki; Nobuo Sakairi; Akimasa Iwado; Tatsuji Yasuda; Takao Koike; Dennis R Voelker; Eiji Matsuura
Journal:  J Lipid Res       Date:  2002-09       Impact factor: 5.922

9.  Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis.

Authors:  Wei Chen; Esad Vucic; Eik Leupold; Willem J M Mulder; David P Cormode; Karen C Briley-Saebo; Alessandra Barazza; Edward A Fisher; Margitta Dathe; Zahi A Fayad
Journal:  Contrast Media Mol Imaging       Date:  2008 Nov-Dec       Impact factor: 3.161

Review 10.  Optical and multimodality molecular imaging: insights into atherosclerosis.

Authors:  Farouc A Jaffer; Peter Libby; Ralph Weissleder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04-09       Impact factor: 8.311

View more
  9 in total

1.  In vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles.

Authors:  Andrei Maiseyeu; Marcus A Badgeley; Thomas Kampfrath; Georgeta Mihai; Jeffrey A Deiuliis; Cuiqing Liu; Qinghua Sun; Sampath Parthasarathy; Daniel I Simon; Kevin Croce; Sanjay Rajagopalan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-02       Impact factor: 8.311

Review 2.  "Eat me" imaging and therapy.

Authors:  Vaishali Bagalkot; Jeffrey A Deiuliis; Sanjay Rajagopalan; Andrei Maiseyeu
Journal:  Adv Drug Deliv Rev       Date:  2016-01-27       Impact factor: 15.470

Review 3.  The year in molecular imaging.

Authors:  Eric A Osborn; Farouc A Jaffer
Journal:  JACC Cardiovasc Imaging       Date:  2012-03

Review 4.  Detection and treatment of atherosclerosis using nanoparticles.

Authors:  Jia Zhang; Yujiao Zu; Chathurika S Dhanasekara; Jun Li; Dayong Wu; Zhaoyang Fan; Shu Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-05-31

5.  Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

Authors:  Claudia Calcagno; Sarayu Ramachandran; Antoine Millon; Philip M Robson; Venkatesh Mani; Zahi Fayad
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-10-14

6.  Nanoparticles target intimal macrophages in atherosclerotic lesions.

Authors:  Chathurika S Dhanasekara; Jia Zhang; Shufang Nie; Guigen Li; Zhaoyang Fan; Shu Wang
Journal:  Nanomedicine       Date:  2020-11-29       Impact factor: 5.307

7.  Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals.

Authors:  Vaishali Bagalkot; Marcus A Badgeley; Thomas Kampfrath; Jeffrey A Deiuliis; Sanjay Rajagopalan; Andrei Maiseyeu
Journal:  J Control Release       Date:  2015-09-18       Impact factor: 9.776

8.  In vitro uptake of apoptotic body mimicking phosphatidylserine-quantum dot micelles by monocytic cell line.

Authors:  Andrei Maiseyeu; Vaishali Bagalkot
Journal:  Nanoscale Res Lett       Date:  2014-04-11       Impact factor: 4.703

9.  Enhancement of Anti-Inflammatory Activity of Curcumin Using Phosphatidylserine-Containing Nanoparticles in Cultured Macrophages.

Authors:  Ji Wang; Yu-Xia Kang; Wen Pan; Wan Lei; Bin Feng; Xiao-Juan Wang
Journal:  Int J Mol Sci       Date:  2016-06-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.